从INBUILD试验中获得的关键经验教训,该试验针对进展性肺纤维化患者
Isabel Mira-Avendano1, Mitchell Kaye2
1Department of Pulmonary, Critical Care and Sleep Medicine, UTHealth, Houston, TX 77030, USA.
Therapeutic advances in respiratory disease
|August 8, 2024
概括
在患有渐进性肺纤维化 (PPF),一种间歇性肺病 (ILD) 的患者中,宁达尼布有效减缓了肺功能下降. 这种抗纤维素药物在各种患者亚组中表现出一致的益处,提供了一种新的治疗选择.
科学领域:
- 肺部病理学 肺部病理学
- 放射学 放射学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 渐进性肺纤维化 (PPF) 是一种严重的间歇性肺病 (ILD),其特征是纤维化恶化,肺功能下降和症状.
- 异形性肺纤维化 (IPF) 是一种特定类型的ILD,但PPF包括其他病因.
- 早期检测和治疗对于管理PPF至关重要.
研究的目的:
- 评估宁泰达尼布在PPF患者中的疗效和安全性.
- 评估宁泰达尼布对肺功能下降速度的影响.
- 为了确定受益于宁泰达尼布治疗的患者子组.
主要方法:
- 在INBUILD试验中,663名PPF患者被随机分配给接受宁泰达尼布或安慰剂.
- 患者接受治疗的中位数约为19个月.
- 使用高分辨率计算机断层扫描 (HRCT) 和肺功能测试来监测疾病进展.
主要成果:
- 与安慰剂相比,丁丁达尼布显著降低了强迫生命能力下降的速度.
- 治疗效果在各种各样的小组中是一致的,包括那些有不同的ILD诊断,HRCT模式,疾病严重程度和同时服用药物 (葡萄皮质激素,DMARDs) 的小组.
- 胃肠道问题,主要是腹,是最常见的不良事件,导致在少数患者中断治疗.
结论:
- 丁丁达尼布是一种有效的治疗选择,可以减缓PPF患者的疾病进展.
- 药物的益处在广泛的PPF患者中是显而易见的,无论其潜在的病因或基线特征如何.
- 及时诊断和启动宁泰达尼布治疗对于管理PPF至关重要.
更多相关视频
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.4K
04:44Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
19.8K
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
164
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
164
01:25Pulmonary Function Tests
313
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
313
01:20COPD: Pathogenesis and Clinical Features
248
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
248